Pkd1 Mutation Has No Apparent Effects on Peroxisome Structure or Lipid Metabolism

Area of Science:

• Cell Biology
• Genetics
• Metabolic Disorders

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) is linked to mitochondrial dysfunction and metabolic reprogramming.
• Peroxisomes interact with mitochondria and their defects can cause kidney cysts and metabolic issues.

Purpose of the Study:

• To investigate if peroxisomal defects contribute to metabolic and mitochondrial impairments in ADPKD.
• To examine the role of peroxisomes in Pkd1-deficient kidney cells and mouse models.

Main Methods:

• Analyzed peroxisome abundance, biogenesis, and morphology in Pkd1 mutant kidney cells.
• Assayed peroxisomal beta-oxidation and fatty acid composition in Pkd1 mutant mice.
• Evaluated peroxisome lipid metabolism in published ADPKD datasets and studied polycystin-1 localization.

Main Results:

• Peroxisome abundance, morphology, and biogenesis were normal in Pkd1 mutant cells.
• Peroxisomal beta-oxidation and very-long-chain fatty acid levels were not impaired.
• Reanalysis of datasets showed no significant peroxisomal abnormalities in ADPKD models, but confirmed mitochondrial defects.

Conclusions:

• Loss of Pkd1 does not disrupt peroxisome biogenesis or function in ADPKD.
• Peroxisomal pathways are not the primary cause of metabolic dysfunction in this ADPKD model.